
Seagen SGEN
Quarterly report 2023-Q3
added 11-01-2023
Seagen Total Inventories 2011-2026 | SGEN
Annual Total Inventories Seagen
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 427 M | 201 M | 116 M | 85.9 M | 53.2 M | 60 M | 68.1 M | 57 M | 43.5 M | 27.1 M | - | 9.47 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 427 M | 9.47 M | 104 M |
Quarterly Total Inventories Seagen
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 531 M | 487 M | 478 M | 427 M | 365 M | - | 276 M | 201 M | 181 M | 163 M | 147 M | 116 M | 116 M | 116 M | 116 M | 85.9 M | 85.9 M | 85.9 M | 85.9 M | 53.2 M | 53.2 M | 53.2 M | 53.2 M | 60 M | 60 M | 60 M | 60 M | 68.1 M | 68.1 M | 68.1 M | 68.1 M | 57 M | 57 M | 57 M | 57 M | 43.5 M | 43.5 M | 43.5 M | 43.5 M | 27.1 M | 27.1 M | 27.1 M | 27.1 M | 37.7 M | 37.7 M | 25.7 M | 15.8 M | 9.47 M | 3.43 M | - | 9.47 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 531 M | 3.43 M | 111 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
ACADIA Pharmaceuticals
ACAD
|
91.7 M | $ 22.56 | 2.13 % | $ 3.74 B | ||
|
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | ||
|
Akebia Therapeutics
AKBA
|
15.6 M | $ 1.43 | 3.62 % | $ 368 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
82.7 M | $ 327.25 | 2.42 % | $ 42.9 B | ||
|
Autolus Therapeutics plc
AUTL
|
33.2 M | $ 1.49 | 9.56 % | $ 397 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
177 M | $ 20.4 | -0.87 % | $ 954 M | ||
|
Aquestive Therapeutics
AQST
|
6.17 M | $ 4.18 | 1.21 % | $ 447 M | ||
|
Aytu BioScience
AYTU
|
11.4 M | $ 2.66 | 3.5 % | $ 16.7 M | ||
|
Arcutis Biotherapeutics
ARQT
|
22.6 M | $ 24.61 | 5.76 % | $ 3.13 B | ||
|
BeiGene, Ltd.
BGNE
|
608 M | - | 0.49 % | $ 251 B | ||
|
Avid Bioservices
CDMO
|
30.4 M | - | - | $ 789 M |